Bloom Health Partners Reports Profitable Fiscal Q2 2022 with $11.1 Million in Revenue Medical Device Investing
Applied UV to Present and Showcase Airocide and Scientific Air Technology at the LD Micro Invitation June 8th, 2022 Medical Device Investing
Abbott's FreeStyle Libre® 3 Receives U.S. FDA Clearance - Features World's Smallest, Thinnest and Most Accurate 14-Day Glucose Sensor Pharmaceutical Investing
Silo Wellness to Create a Psychedelic Pharmaceutical Manufacturing and Research Portfolio with Proposed Acquisition of Dyscovry Science Psychedelics Investing
Albert Labs: Treating Cancer-Related Distress With Psilocybin-Based Medication Psychedelics Investing
Optimi Health: Natural Psychedelic Wellness Alternatives Capitalizing Diverse Revenue Streams Psychedelics Investing
LAWSUITS FILED AGAINST ABBV, SDIG and AUPH - Jakubowitz Law Pursues Shareholders Claims Pharmaceutical Investing
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SDIG, AUPH and UPST Pharmaceutical Investing
SHAREHOLDER ALERT: VLTA ABBV LILM: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines Pharmaceutical Investing
7-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in AbbVie Inc. with Losses of $100,000 to Contact the Firm Pharmaceutical Investing
Marvel Biosciences Reports MB-204 as Highly Effective at Treating Autism Behaviours in Shank3 Mouse Model
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
